Portfolio
RusnanoMedInvest specializes in investment in the companies bringing to the market novel medical products
- We are interested in investment in the companies that have depeloped and bringing to the market innovative medicines and medical equipment products (production and sales expansion)
- In certain cases we are ready to support projects at later stages of the development (products with proven therapeutic efficacy by the completion of Phase 2/3 clinical studies)
Our portfolio companies:
Portfolio companies news
-
Clearside Biomedical, Inc. (“Clearside”), (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that data from PEACHTREE, its pivotal Phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be shared as a late-breaking oral presentation during the 2018 annual meeting of the American Society of Retina Specialists , July 20-25 in Vancouver, Canada .
-
11 July 2018
Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
-
10 July 2018
Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer
-
21 June 2018
Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index